Skip to main content
. 2016 Dec 19;28(3):611–621. doi: 10.1093/annonc/mdw660

Figure 6.

Figure 6

ATRA-21 sensitivity predictions across tumor types. The box plots illustrate the distribution of ATRA-21 sensitivity predictions after grouping of the tumor types (TCGA database). In the case of breast cancer and acute myeloid leukemias, cases are stratified according to immuno-histochemical subtype and FAB classification, respectively. ER+, estrogen-receptor-positive; H+, HER2-positive; TN, triple-negative; 0–7, FAB-subtypes M0 to M7.